The Valley Desk

NCT05885412 · Interventional trial

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Overall registry status Recruiting

Phase 1

Conditions PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov